8-KRegulation FD

PEPSICO INC 8-K Report, Regulation FD Disclosure (Feb 14, 2013)

Filed February 14, 2013For Securities:PEP

Summary

PepsiCo, Inc. (PEP) filed an 8-K on February 14, 2013, to provide a clarification regarding its beverage innovation projects. The company addressed questions raised during its earnings call, stating that while preparatory work for review and commercialization of potential new beverage innovations is underway, these innovations have not yet been submitted to the FDA. PepsiCo expects to make submissions to the appropriate regulatory bodies once this preparatory work is successfully completed. This filing serves as a crucial update for investors concerned about the pipeline and regulatory progress of PepsiCo's product development. The clarification aims to manage expectations regarding the timeline for new product launches and to ensure transparency in the regulatory approval process. Investors should note that this information is being furnished and is not deemed 'filed' for certain legal purposes, meaning it does not carry the same liability as a formal filing but provides timely disclosure.

Key Highlights

  • 1PepsiCo clarified its status on beverage innovation projects following an earnings call.
  • 2Preparatory work for review and commercialization of potential beverage innovations is ongoing.
  • 3No potential beverage innovations have yet been submitted to the FDA.
  • 4Submissions to the appropriate reviewing body will be made after successful completion of preparation work.
  • 5The company is providing this update in response to investor inquiries.
  • 6This disclosure is furnished under Regulation FD and is not deemed 'filed' for Section 18 purposes.

Frequently Asked Questions

The main purpose of this 8-K filing is to clarify PepsiCo's progress on its beverage innovation projects, specifically addressing concerns raised during a recent earnings call about FDA submissions.

No, as of the filing date of February 14, 2013, PepsiCo has not yet submitted any potential beverage innovations to the FDA. Preparatory work is still in progress.

PepsiCo stated that submissions will be made to the appropriate reviewing body only after the necessary preparation work for review and commercialization has been successfully completed.

This clarification helps manage investor expectations regarding the timeline for new product introductions and the regulatory approval process. It signals that while innovation is in development, market readiness is contingent on successful regulatory clearance.